December 07, 2025 a 04:38 pm
CLX: Analysts Ratings - The Clorox Company
The Clorox Company, operating in diverse consumer and professional product segments, has seen varied analyst ratings over the months. With a majority leaning towards 'Hold', it reflects a cautious sentiment in the market. Recent trends suggest stability in expectations with limited strong buy signals.
Historical Stock Grades
| Recommendation | Count | Score Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 2 | |
| Hold | 13 | |
| Sell | 2 | |
| Strong Sell | 2 |
Sentiment Development
Over the recent months, there has been a noticeable stability in the 'Hold' category. While 'Strong Buy' recommendations remain non-existent in the latest data, an uptick in 'Hold' indicates a more neutral market stance. The 'Buy' and 'Sell' categories have remained relatively static, hinting at consolidated market views.
- The overall number of ratings has remained consistent, with minor fluctuations noted in 'Strong Buy' ratings.
- A marked increase in 'Hold' ratings juxtaposes the decrease in 'Strong Buy' categories.
- Trends indicate a cautious yet steady sentiment with minimal shifts towards aggressive buying or selling.
Percentage Trends
The percentage compositions of ratings reveal a clear shift from 'Strong Buy' to a more reserved 'Hold'. This hints at growing caution among analysts. The predominance of 'Hold' ratings underscores a market waiting for further clarity before committing to any significant movements.
- 'Strong Buy' consistently drops to 0% by the latest reading, with 'Buy' maintaining a minor share.
- A sharp increase in 'Hold' percentage, upholding market neutrality.
- Overall, a reduction in enthusiasm for aggressive positions in either direction is evident.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-04 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-11-04 | Neutral | Neutral | JP Morgan |
| 2025-11-04 | Neutral | Neutral | Citigroup |
| 2025-11-04 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-10-10 | Neutral | Neutral | JP Morgan |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-01-07 | Equal Weight | Underweight | Wells Fargo |
| 2024-11-06 | Hold | Sell | TD Cowen |
| 2024-10-01 | Buy | Hold | Jefferies |
| 2024-04-02 | Neutral | Buy | Citigroup |
| 2024-03-26 | Hold | Underperform | Jefferies |
Interpretation
The Clorox Company presents a picture of stability with prevalent 'Hold' recommendations reflecting market caution. The relative absence of 'Strong Buy' ratings indicates a lack of bullish sentiment, pointing to apprehension about market conditions. The steadiness in the majority of the recommendations signifies consistency and offers a view of balanced uncertainty rather than exuberant confidence. Overall, analysts exhibit measured optimism while awaiting further developments in the broader market.
Conclusion
The recent analysis of The Clorox Company's stock indicates a cautious optimism from analysts. With a notable presence of 'Hold' ratings, the market appears to be in a wait-and-see mode, reflecting a stable yet uncertain outlook. The lack of strong buying signals and consistent neutral ratings underscore a pared-back risk appetite. Moving forward, any changes in macroeconomic factors or company-specific news could serve as catalysts for a reevaluation of market sentiment. For now, Clorox's stock is positioned in a balanced state, awaiting definitive market cues.